fondaparinux

Hip Fracture Surgery Arterial and Venous Thrombotic Events Prevention

Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis

Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients

Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia

Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19

Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)

Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia (HIT)

Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients

Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower Limbs

Hip Fracture Study of GSK576428 (Fondaparinux Sodium)

Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)

Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II

Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery

Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux

Michelangelo - Oasis 5

Study to Determine Effective Dosing of Fondaparinux in Obese Persons

Fondaparinux in Critically Ill Patients With Renal Failure

Fondaparinux EU-RMP (Adherence)